Suppr超能文献

多中心、单盲、随机、平行分组研究评价鼻牙槽塑形治疗非综合征型完全性单侧唇裂、牙槽突裂和腭裂患者的有效性(NAMUC 研究):一项随机对照试验的研究方案。

A multi-centric, single-blinded, randomized, parallel-group study to evaluate the effectiveness of nasoalveolar moulding treatment in non-syndromic patients with complete unilateral cleft lip, alveolus and palate (NAMUC study): a study protocol for a randomized controlled trial.

机构信息

Cleft and Craniofacial Department, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, Velachery Main Road, Chennai, Tamil Nadu, 600100, India.

Bhagavan Mahaveer Jain Hospital, Bangalore, India.

出版信息

Trials. 2024 Jul 4;25(1):453. doi: 10.1186/s13063-024-08229-z.

Abstract

BACKGROUND

Cleft lip and palate (CLP) are among the most common congenital anomaly that affects up to 33,000 newborns in India every year. Nasoalveolar moulding (NAM) is a non-surgical treatment performed between 0 and 6 months of age to reduce the cleft and improve nasal aesthetics prior to lip surgery. The NAM treatment has been a controversial treatment option with 51% of the cleft teams in Europe, 37% of teams in the USA and 25 of cleft teams in India adopting this methodology. This treatment adds to the already existing high burden of care for these patients. Furthermore, the supporting evidence for this technique is limited with no high-quality long-term clinical trials available on the effectiveness of this treatment.

METHOD

The NAMUC study is an investigator-initiated, multi-centre, single-blinded randomized controlled trial with a parallel group design. The study will compare the effectiveness of NAM treatment provided prior to lip surgery against the no-treatment control group in 274 patients with non-syndromic unilateral complete cleft lip and palate. The primary endpoint of the trial is the nasolabial aesthetics measured using the Asher McDade index at 5 years of age. The secondary outcomes include dentofacial development, speech, hearing, cost-effectiveness, quality of life, patient perception, feeding and intangible benefits. Randomization will be carried out via central online system and stratified based on cleft width, birth weight and clinical trial site.

DISCUSSION

We expect the results from this study on the effectiveness of treatment with NAM appliance in the long term along with the cost-effectiveness evaluation can eliminate the dilemma and differences in clinical care across the globe.

TRIAL REGISTRATION

ClinicalTrials.gov CTRI/2022/11/047426 (Clinical Trials Registry India). Registered on 18 November 2022. The first patient was recruited on 11 December 2022. CTR India does not pick up on Google search with just the trial number. The following steps have to be carried out to pick up. How to search: ( https://ctri.nic.in/Clinicaltrials/advsearch.php -use the search boxes by entering the following details: Interventional trial > November 2022 > NAMUC).

摘要

背景

唇腭裂是最常见的先天性畸形之一,印度每年有多达 33000 名新生儿受其影响。鼻牙槽塑形术(NAM)是一种非手术治疗方法,在 0 至 6 个月大时进行,以缩小裂隙并改善唇裂术前的鼻部美学。NAM 治疗一直是一个有争议的治疗选择,欧洲 51%的腭裂团队、美国 37%的团队和印度 25%的腭裂团队采用了这种方法。这种治疗方法增加了这些患者已经存在的高护理负担。此外,由于没有关于这种治疗效果的高质量长期临床试验,因此该技术的支持证据有限。

方法

NAMUC 研究是一项由研究者发起的、多中心、单盲、随机对照临床试验,采用平行分组设计。该研究将比较唇裂术前提供的 NAM 治疗与无治疗对照组在 274 例非综合征性单侧完全唇腭裂患者中的效果。试验的主要终点是 5 岁时使用 Asher McDade 指数测量的鼻唇美学。次要结果包括牙颌面发育、言语、听力、成本效益、生活质量、患者感知、喂养和无形效益。随机化将通过中央在线系统进行,并根据裂隙宽度、出生体重和临床试验地点进行分层。

讨论

我们预计这项关于 NAM 矫治器长期治疗效果的研究结果以及成本效益评估,可以消除全球范围内的治疗困境和临床护理差异。

试验注册

ClinicalTrials.gov CTRI/2022/11/047426(印度临床试验注册中心)。于 2022 年 11 月 18 日注册。首例患者于 2022 年 12 月 11 日招募。CTRI India 在谷歌搜索中仅通过试验编号无法搜索到。要搜索,需要按照以下步骤进行:(https://ctri.nic.in/Clinicaltrials/advsearch.php-使用搜索框,输入以下详细信息:干预性试验>2022 年 11 月>NAMUC)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ce6/11223389/2e575828f16a/13063_2024_8229_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验